Lindbrook Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-227
Closed -$2K 2859
2022
Q1
$2K Buy
+227
New +$1.94K ﹤0.01% 2131

Other funds holding DBD

Lindbrook Capital's DBD Position: Q2 2022 in Review

Lindbrook Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 227 shares — an estimated $2K sold.

Lindbrook Capital first reported a position in DBD in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • Lindbrook Capital reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • Lindbrook Capital sold 227 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $2K.
  • Lindbrook Capital first reported a position in Diebold Nixdorf Incorporated in Q1 2022 and held it in 1 quarter.
  • Lindbrook Capital's Diebold Nixdorf Incorporated position peaked at $2K in Q1 2022.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on Lindbrook Capital's 13F filing for Q2 2022, filed 1 Aug 2022.